Cargando…
Association between genome-wide epigenetic and genetic alterations in breast cancer tissue and response to HER2-targeted therapies in HER2-positive breast cancer patients: new findings and a systematic review
Recent evidence suggests that genetic and epigenetic mechanisms might be associated with acquired resistance to cancer therapies. The aim of this study was to assess the association of genome-wide genetic and epigenetic alterations with the response to anti-HER2 agents in HER2-positive breast cancer...
Autores principales: | Furrer, Daniela, Dragic, Dzevka, Chang, Sue-Ling, Fournier, Frédéric, Droit, Arnaud, Jacob, Simon, Diorio, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771759/ https://www.ncbi.nlm.nih.gov/pubmed/36627894 http://dx.doi.org/10.20517/cdr.2022.63 |
Ejemplares similares
-
Trastuzumab effects depend on HER2 phosphorylation in HER2-negative breast cancer cell lines
por: Burguin, Anna, et al.
Publicado: (2020) -
Epigenome-wide DNA methylation and risk of breast cancer: a systematic review
por: Ennour-Idrissi, Kaoutar, et al.
Publicado: (2020) -
DNA Methylation and Breast Cancer Risk: An Epigenome-Wide Study of Normal Breast Tissue and Blood
por: Ennour-Idrissi, Kaoutar, et al.
Publicado: (2020) -
Validation of a new classifier for the automated analysis of the human epidermal growth factor receptor 2 (HER2) gene amplification in breast cancer specimens
por: Furrer, Daniela, et al.
Publicado: (2013) -
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021)